Skip to main content

Business

By Jessica Hagen | 01:40 pm | April 18, 2023
The funds will be used to scale the company's AI-enabled care navigation platform with healthcare systems.
By Emily Olsen | 10:06 am | April 17, 2023
Craig Anderson, director of innovation at the Florida-based health system, discusses what the health system has learned from implementing the voice assistant.
HIMSS23
By HIMSS TV | 06:54 pm | April 14, 2023
Mark Zandi, Moody's Analytics chief economist, predicts that finding and retaining health workers will remain tough while supply chain issues will continue to improve.
By Jessica Hagen | 12:38 pm | April 14, 2023
1upHealth and Spring Health also secured financing.
HIMSS23
By HIMSS TV | 07:00 am | April 14, 2023
Didi Davis, VP of informatics, conformance and interoperability at the Sequoia Project, discusses the HIMSS23 panel highlighting the company's recommendations on ensuring secure but ubiquitous interoperability across U.S. healthcare.
HIMSS23
By HIMSS TV | 04:31 pm | April 13, 2023
Trent Sanders, VP of healthcare, U.S., at Kyndryl, previewing his HIMSS23 presentation, talks about avoiding technology bottlenecks in the revenue cycle processes to improve employee engagement, drive increased revenue and reduce costs.
HIMSS23
By HIMSS TV | 03:19 pm | April 13, 2023
At HIMSS23, David Murtagh, VP of operations at MultiPlan, which cofounded the group with United Healthcare, Humana and others, will speak about payer and provider use cases that are emerging for the distributed ledger.
HIMSS23
By HIMSS TV | 03:00 pm | April 13, 2023
A stand-alone EHR workflow automates prior authorizations via workflow optimization and process modifications, reducing wait times for radiology at Atlantic Health System, according to Danielle Pieloch and Kumar Aditya in their HIMSS23 presentation.
By Jessica Hagen | 11:57 am | April 13, 2023
The funds will be used to scale and advance the company's Digital Medical Home care model.
By Emily Olsen | 02:09 pm | April 12, 2023
A federal jury found three former executives guilty of defrauding investors and clients, largely pharma companies.